Related Experiment Video
Updated: Aug 24, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Inhibition of the Staphylococcus aureus sortase transpeptidase SrtA by phosphinic peptidomimetics
Ryan G Kruger1, Salim Barkallah, Brenda A Frankel
1Department of Biochemistry and Biophysics and the Johnson Research Foundation, The University of Pennsylvania School of Medicine, 905A Stellar-Chance Building, 422 Curie Blvd., Philadelphia, PA 19104-6059, USA.
Abstract:
During pathogenesis, Gram-positive bacteria utilize surface protein virulence factors such as the MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) to aid the initiation and propagation of infection through adherence to host endothelial tissue and immune system evasion. These virulence-associated proteins generally contain a C-terminal LPXTG motif that becomes covalently anchored to the peptidoglycan biosynthesis intermediate lipid II. In Staphylococcus aureus, deletion of the sortase isoform SrtA results in marked reduction in virulence and infection potential, making it an important antivirulence target. Here we describe the chemical synthesis and kinetic characterization of a nonhydrolyzable phosphinic peptidomimetic inhibitor of SrtA derived from the LPXTG substrate sequence.
Insights
Researchers developed a novel phosphinic peptidomimetic inhibitor targeting the SrtA enzyme in Staphylococcus aureus. This inhibitor blocks surface protein anchoring, offering a promising antivirulence strategy against Gram-positive bacterial infections.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Gram-positive bacteria use surface proteins like MSCRAMMs for infection.
- These proteins anchor to peptidoglycan via the LPXTG motif and sortase enzymes.
- Staphylococcus aureus SrtA is a key virulence factor and antivirulence target.
Purpose of the Study:
- To design and synthesize a nonhydrolyzable inhibitor of the SrtA enzyme.
- To investigate the kinetic properties of this novel inhibitor.
- To explore a new antivirulence strategy against Staphylococcus aureus.
Main Methods:
- Chemical synthesis of a phosphinic peptidomimetic.
- Kinetic characterization of the SrtA inhibitor.
- Utilizing the LPXTG substrate sequence for inhibitor design.
Main Results:
- Successful chemical synthesis of a nonhydrolyzable SrtA inhibitor.
- Characterization of the inhibitor's kinetic parameters.
- Demonstration of a peptidomimetic approach for sortase inhibition.
Conclusions:
- The developed phosphinic peptidomimetic effectively inhibits SrtA.
- This inhibitor represents a potential therapeutic agent against Staphylococcus aureus infections.
- Targeting sortase-mediated anchoring offers a viable antivirulence strategy.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing

